Measuring the Effectiveness of the 340B Program

15 Pages Posted: 20 Nov 2018

See all articles by Bruce Levinson

Bruce Levinson

Center for Regulatory Effectiveness

Date Written: November 1, 2018


Virtually every aspect of the 340B drug discount program has been evaluated except its effectiveness at improving healthcare access for medically underserved populations. This paper seeks to fill this information gap by using federal data to measure changes in the ability of impoverished and uninsured patients to afford needed healthcare, relative to the general population. The paper finds that the 340B program is harming the relative affordability of needed prescription drugs, needed medical care, and needed dental care for the most medically underserved communities. The causes of this decline in affordability is traced to a three-fold process that 340B hospitals are using to take maximum advantage of the program’s financial incentives.

Keywords: 340B, hospitals, pharmacies, medically underserved, program effectiveness

JEL Classification: I11, I14, I18

Suggested Citation

Levinson, Bruce, Measuring the Effectiveness of the 340B Program (November 1, 2018). Available at SSRN: or

Bruce Levinson (Contact Author)

Center for Regulatory Effectiveness ( email )

1601 Connecticut Avenue, NW
Washington, DC 20009
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Abstract Views
PlumX Metrics